NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/11/2025
Back to search
Official data from USPTO
CLINICAL CURCUMIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINICAL CURCUMIN
ST13
US500000087321164Class
5
Filing
87321164
Registration
5567350
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/11/2025
Trademark type
Word
Nice classes
5
Filing date
02/01/2017
Registration date
09/18/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
03/11/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
02/01/2017
First use in commerce
02/01/2017
Drawing code
4
Owner type
03
Owner location
Plainview, NY
Examiner
CROSS, TRACY L
Current location
Historical data usage
Holders and representatives
Holders
Water Pure, Inc.
Representatives
Arlir Amado KRAMER AMADO P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary and nutritional supplements containing curcumin
Publications
History of USPTO decisions and trademark events.
31 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/11/2025
ES8R
TEAS SECTION 8 RECEIVED
07/16/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/18/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
09/18/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/14/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
08/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/06/2018
ALIE
ASSIGNED TO LIE
08/06/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/06/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/06/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/06/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/14/2018
GNRT
NON-FINAL ACTION E-MAILED
02/14/2018
CNRT
NON-FINAL ACTION WRITTEN
02/14/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2018
ALIE
ASSIGNED TO LIE
01/22/2018
NREV
NOTICE OF REVIVAL - E-MAILED
01/05/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2018
PETG
PETITION TO REVIVE-GRANTED
01/05/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
01/05/2018
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
12/11/2017
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
12/08/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/04/2017
GNRT
NON-FINAL ACTION E-MAILED
05/04/2017
CNRT
NON-FINAL ACTION WRITTEN
05/04/2017
DOCK
ASSIGNED TO EXAMINER
04/26/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/06/2017
NWAP
NEW APPLICATION ENTERED
02/04/2017
Continuous trademark protection
Get notified about every new filing that threatens CLINICAL CURCUMIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.